Russell Investments Group Ltd. Sells 14,593 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Key Points

• Russell Investments Group Ltd. reduced its stake in HCA Healthcare by 2.7%, selling 14,593 shares, and now holds approximately 529,567 shares valued at $182.96 million.
• HCA Healthcare reported earnings of $6.84 per share for the latest quarter, surpassing analysts' expectations of $6.20 and reflecting a revenue growth of 6.4% year-over-year.
• The company announced a quarterly dividend of $0.72 per share, with a yield of 0.8%, to be paid on September 30th to investors of record on September 16th.

Russell Investments Group Ltd. lowered its position in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 2.7% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 529,567 shares of the company's stock after selling 14,593 shares during the quarter. Russell Investments Group Ltd. owned approximately 0.22% of HCA Healthcare worth $182,961,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors have also bought and sold shares of the company. Cheviot Value Management LLC purchased a new stake in shares of HCA Healthcare during the first quarter valued at approximately $26,000. Atwood & Palmer Inc. purchased a new stake in shares of HCA Healthcare during the first quarter valued at approximately $28,000. Bartlett & CO. Wealth Management LLC boosted its stake in shares of HCA Healthcare by 888.9% during the first quarter. Bartlett & CO. Wealth Management LLC now owns 89 shares of the company's stock valued at $31,000 after purchasing an additional 80 shares during the period. ORG Partners LLC lifted its stake in HCA Healthcare by 344.0% in the first quarter. ORG Partners LLC now owns 111 shares of the company's stock worth $38,000 after acquiring an additional 86 shares during the period. Finally, Migdal Insurance & Financial Holdings Ltd. lifted its stake in HCA Healthcare by 75.8% in the first quarter. Migdal Insurance & Financial Holdings Ltd. now owns 116 shares of the company's stock worth $40,000 after acquiring an additional 50 shares during the period. Hedge funds and other institutional investors own 62.73% of the company's stock.

HCA Healthcare Stock Performance

Shares of HCA Healthcare stock opened at $382.90 on Tuesday. HCA Healthcare, Inc. has a 52 week low of $289.98 and a 52 week high of $417.14. The company has a market capitalization of $89.60 billion, a PE ratio of 16.10, a price-to-earnings-growth ratio of 1.20 and a beta of 1.39. The stock's fifty day moving average is $369.76 and its two-hundred day moving average is $350.02. The company has a quick ratio of 0.86, a current ratio of 0.98 and a debt-to-equity ratio of 69.07.

HCA Healthcare (NYSE:HCA - Get Free Report) last issued its earnings results on Friday, July 25th. The company reported $6.84 earnings per share for the quarter, topping the consensus estimate of $6.20 by $0.64. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%. The business had revenue of $18.61 billion during the quarter, compared to analysts' expectations of $18.49 billion. During the same period in the prior year, the business earned $5.50 EPS. The business's revenue for the quarter was up 6.4% compared to the same quarter last year. As a group, analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 30th. Investors of record on Tuesday, September 16th will be given a dividend of $0.72 per share. This represents a $2.88 annualized dividend and a yield of 0.8%. The ex-dividend date of this dividend is Tuesday, September 16th. HCA Healthcare's dividend payout ratio is currently 12.11%.

Wall Street Analysts Forecast Growth

A number of analysts recently commented on HCA shares. Royal Bank Of Canada dropped their price target on HCA Healthcare from $404.00 to $401.00 and set an "outperform" rating for the company in a research note on Monday, July 28th. Wolfe Research lowered HCA Healthcare from an "outperform" rating to a "peer perform" rating in a research note on Monday, July 28th. JPMorgan Chase & Co. increased their price objective on HCA Healthcare from $360.00 to $370.00 and gave the stock a "neutral" rating in a report on Monday, August 4th. Barclays reduced their price target on HCA Healthcare from $416.00 to $390.00 and set an "overweight" rating for the company in a report on Monday, July 28th. Finally, Morgan Stanley dropped their price objective on HCA Healthcare from $410.00 to $400.00 and set an "equal weight" rating on the stock in a research report on Monday, July 28th. Nine analysts have rated the stock with a hold rating, nine have given a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus target price of $395.69.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.